Ideaya Biosciences, Inc. (IDYA)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$30.65-5.28%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · IDYA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | — | 218.7 | 7.0 | 23.4 | 50.9 | 27.9 | 19.5 | — |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 412.6 | 314.7 | 294.7 | 129.5 | 89.5 | 58.2 | 39.7 | 34.3 |
| Operating Income | (463.0) | (159.3) | (327.0) | (134.4) | (62.5) | (50.3) | (35.3) | (44.3) |
| Earnings from Continuing Operations | ||||||||
| Interest & Investment Income | — | — | — | — | — | — | — | 2.3 |
| Other Non-Operating Income / Expenses | 43.0 | 45.6 | 52.5 | 21.5 | 3.8 | 0.5 | 0.8 | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | ||||||||
| Net Income | (420.0) | (113.7) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) |
| Per Share | ||||||||
| Basic EPS | (4.08) | (1.28) | (3.36) | (1.96) | (1.42) | (1.41) | (1.40) | — |
| Diluted EPS | (4.08) | (1.28) | (3.36) | (1.96) | (1.42) | (1.41) | (1.40) | — |
| Basic Weighted Avg Shares | 102.9 | 88.5 | 81.7 | 57.5 | 41.4 | 35.3 | 24.7 | — |
| Diluted Weighted Avg Shares | 102.9 | 88.5 | 81.7 | 57.5 | 41.4 | 35.3 | 24.7 | — |
| Supplemental | ||||||||
| EBITDA | — | (156.6) | (324.6) | (131.9) | (60.4) | (48.6) | (33.9) | (42.9) |
| EBIT | (463.0) | (159.3) | (327.0) | (134.4) | (62.5) | (50.3) | (35.3) | (44.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.